Induced disruption of the iron-regulatory hormone hepcidin inhibits acute inflammatory hypoferraemia

Journal of Innate Immunity

Volumn 8, Issue 5, 2016, Pages 517-528

  Armitage, Andrew E ^b   Lim, Pei Jin ^b   Frost, Joe N ^b   Pasricha, Sant Rayn ^b   Soilleux, Elizabeth J ^c   Evans, Emma ^a   Morovat, Alireza ^d   Santos, Ana ^e   Diaz, Rebeca ^e   Biggs, Daniel ^e   Davies, Benjamin ^e   Gileadi, Uzi ^b   Robbins, Peter A ^c   Lakhal Littleton, Samira ^c   Drakesmith, Hal ^b,f  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Hepcidin; Hypoferraemia; Inflammation; Iron

Indexed keywords

FERROPORTIN; FERROPORTIN 1; HEPCIDIN; IRON; LIPOPOLYSACCHARIDE; MESSENGER RNA; BACTERIAL ANTIGEN; LIPOPEPTIDE; PAM(3)CSK(4) PEPTIDE; TOLL LIKE RECEPTOR;

ACUTE INFLAMMATORY HYPOFERRAEMIA; ACUTE PHASE RESPONSE; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUCELLA ABORTUS; CONTROLLED STUDY; EXON; FEMALE; GENE DELETION; GENE DISRUPTION; GENE LOSS; HORMONE ACTION; HORMONE BLOOD LEVEL; INFLAMMATORY DISEASE; INNATE IMMUNITY; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; ANIMAL; C57BL MOUSE; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; INFLAMMATION; IRON METABOLISM DISORDER; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY;

ANIMALS; ANTIGENS, BACTERIAL; BRUCELLA ABORTUS; GENOTYPE; HEPCIDINS; HUMANS; INFLAMMATION; IRON METABOLISM DISORDERS; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; TOLL-LIKE RECEPTORS;

EID: 84979010353     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000447713     Document Type: Article

References (37)

1. Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nature Rev Immunol 2015; 15: 500-510
2. Payne SM, Finkelstein RA. The critical role of iron in host-bacterial interactions. J Clin Invest 1978; 61: 1428-1440
3. Weinberg ED Iron withholding: a defense against infection and neoplasia. Physiol Rev 1984; 64: 65-e02
4. Cartwright GE, Lauritsen MA, Jones PJ, Merrill IM, Wintrobe MM. The anemia of infection. I. Hypoferremia, hypercupremia, and alterations in porphyrin metabolism in patients. J Clin Invest 1946; 25: 65-80
5. Arezes J, Jung G, Gabayan V, Valore E, Ruchala P, Gulig PA, Ganz T, Nemeth E, Bulut Y. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus . Cell Host Microbe 2015; 17: 47-57
6. Abboud S, Haile DJ: A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000; 275: 19906-19912
7. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000; 403: 776-781
8. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ: A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000; 5: 299-309
9. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science (New York) 2004; 306: 2090-2093
10. Zumerle S, Mathieu JR, Delga S, Heinis M, Viatte L, Vaulont S, Peyssonnaux C. Targeted disruption of hepcidin in the liver recapitulates the hemochromatotic phenotype. Blood 2014; 123: 3646-3650
11. Lesbordes-Brion JC, Viatte L, Bennoun M, Lou DQ, Ramey G, Houbron C, Hamard G, Kahn A, Vaulont S. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 2006; 108: 1402-1405
12. Deschemin JC, Vaulont S. Role of hepcidin in the setting of hypoferremia during acute inflammation. PLoS One 2013; 8:e61050
13. Lakhal-Littleton S, Wolna M, Carr CA, Miller JJ, Christian HC, Ball V, Santos A, Diaz R, Biggs D, Stillion R, Holdship P, Larner F, Tyler DJ, Clarke K, Davies B, Robbins PA. Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc Natl Acad Sci USA 2015; 112: 3164-3169
14. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, Newman J, Reczek EE, Weissleder R, Jacks T. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445: 661-665
15. Armitage AE, Eddowes LA, Gileadi U, Cole S, Spottiswoode N, Selvakumar TA, Ho LP, Townsend AR, Drakesmith H. Hepcidin regulation by innate immune and infectious stimuli. Blood 2011; 118: 4129-4139
16. Iron Panel of the International Committee for Standardization in Haematology: Revised recommendations for the measurements of the serum iron in human blood. Br J Haematol 1990; 75: 615-616
17. Kautz L, Meynard D, Monnier A, Darnaud V, Bouvet R, Wang RH, Deng C, Vaulont S, Mosser J, Coppin H, Roth MP. Iron regulates phosphorylation of smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 2008; 112: 1503-1509
18. Yang Q, Jian J, Katz S, Abramson SB, Huang X: 17β-estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology 2012; 153: 3170-3178
19. Courselaud B, Troadec MB, Fruchon S, Ilyin G, Borot N, Leroyer P, Coppin H, Brissot P, Roth MP, Loreal O. Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice. Blood Cell Mol Dis 2004; 32: 283-289
20. Guida C, Altamura S, Klein FA, Galy B, Boutros M, Ulmer AJ, Hentze MW, Muckenthaler MU: A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia. Blood 2015; 125: 2265-2275
21. Sasu BJ, Cooke KS, Arvedson TL, Plewa C, Ellison AR, Sheng J, Winters A, Juan T, Li H, Begley CG, Molineux G. Anti-hepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammationinduced anemia. Blood 2010; 115: 3616-3624
22. Silva B, Faustino P. An overview of molecular basis of iron metabolism regulation and the associated pathologies. Biochim Biophys Acta 2015; 1852: 1347-1359
23. Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 2005; 106: 2196-2199
24. Du X, She E, Gelbart T, Truksa J, Lee P, Xia Y, Khovananth K, Mudd S, Mann N, Moresco EM, Beutler E, Beutler B. The serine protease TMPRSS6 is required to sense iron deficiency. Science (New York) 2008; 320: 1088-1092
25. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, Mayo MM, Samuel SM, Strouse JJ, Markianos K, Andrews NC, Fleming MD. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 2008; 40: 569-571
26. Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science (New York) 2012; 338: 768-772
27. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101: 2461-2463
28. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002; 110: 1037-1044
29. Cooke KS, Hinkle B, Salimi-Moosavi H, Foltz I, King C, Rathanaswami P, Winters A, Steavenson S, Begley CG, Molineux G, Sasu BJ: A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates. Blood 2013; 122: 3054-3061
30. Van Eijk LT, John AS, Schwoebel F, Summo L, Vauleon S, Zollner S, Laarakkers CM, Kox M, Van Der Hoeven JG, Swinkels DW, Riecke K, Pickkers P. Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans. Blood 2014; 124: 2643-2646
31. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 2009; 41: 478-481
32. Fleming RE, Ahmann JR, Migas MC, Waheed A, Koeffler HP, Kawabata H, Britton RS, Bacon BR, Sly WS. Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proc Natl Acad Sci USA 2002; 99: 10653-10658
33. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, Fei Y, Brunt EM, Ruddy DA, Prass CE, Schatzman RC, O Neill R, Britton RS, Bacon BR, Sly WS. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998; 95: 2492-2497
34. Iancu TC, Deugnier Y, Halliday JW, Powell LW, Brissot P. Ultrastructural sequences during liver iron overload in genetic hemochromatosis. J Hepatol 1997; 27: 628-638
35. Schwoebel F, Van Eijk LT, Zboralski D, Sell S, Buchner K, Maasch C, Purschke WG, Humphrey M, Zollner S, Eulberg D, Morich F, Pickkers P, Klussmann S. The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation- induced anemia in cynomolgus monkeys. Blood 2013; 121: 2311-2315
36. Yang F, Liu XB, Quinones M, Melby PC, Ghio A, Haile DJ. Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J Biol Chem 2002; 277: 39786-39791
37. Ludwiczek S, Aigner E, Theurl I, Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003; 101: 4148-4154